Our therapy areas
The path to new treatments
The future of treatment for many of today's diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. We focus on a number of key areas – Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. We are also selectively active in the areas of autoimmunity, neuroscience and infection.
BioPharmaceuticals
BioPharmaceuticals is responsible for our therapy areas of Cardiovascular, Renal & Metabolism and Respiratory & Immunology and Infectious Disease. Through our work in BioPharmaceuticals, we aim to transform health care and deliver life-changing medicines for people living with the most common chronic diseases.
Oncology
AstraZeneca's vision is to respond to unmet medical need by redefining the cancer treatment paradigm. This is being achieved through scientific innovation, accelerated clinical programmes and collaboration. We have a strong heritage - more than 40 years - in developing cancer treatments.
Our broad pipeline of next generation medicines is focused on five main disease areas: prostate, breast, ovarian, lung and haematological cancers, using four key scientific approaches: immunotherapy, tumour drivers and resistance mechanisms, and DNA damage.
We are focused on identifying and developing combination therapies. Our immuno-oncology portfolio, enables us to explore and exploit scientific and biological synergies to pursue combinations that improve outcomes and maximise patient benefit.